Standard BioTools Inc. (LAB)
LAB moved a median of +0.08% 30 minutes after news, and -0.42% by the close. How LAB actually reacts to news — the realized, point-in-time move the market made, measured across 350 labeled events over the last three years with zero look-ahead.
LAB’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 350 |
| 30-min | +0.08% | 52% | 350 |
| 60-min | 0.00% | 50% | 350 |
| to close | -0.42% | 43% | 346 |
| Middle 50% of LAB reactions | -1.41% to +1.76% |
|---|---|
| Median reaction (30-min) | +0.08% |
| Measured reactions | 350 |
Half of all Standard BioTools Inc. news events land between -1.41% and +1.76% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when LAB moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LAB's baseline. Nothing else.
Recent LAB events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form S-4/A STANDARD BIOTOOLS INC. | SEC filing · Form S-4 | SEC EDGAR | -1.61% | -3.41% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Oct 05 | SEC filing · Form 8-K | SEC EDGAR | +1.38% | -6.75% | |
| Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED | Press release | GlobeNewswire | +1.38% | -6.75% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | -1.34% | -1.57% | |
| Standard BioTools Provides Update on Sale of Mass Cytometry Business | Press release | GlobeNewswire | -1.34% | -1.57% | |
| Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.11% | -0.12% | |
| Form S-4/A STANDARD BIOTOOLS INC. | SEC filing · Form S-4 | SEC EDGAR | -0.49% | -3.34% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.42% | +4.26% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +2.42% | +4.26% | |
| Form S-8 STANDARD BIOTOOLS INC. | SEC filing · Form S-8 | SEC EDGAR | +2.42% | +4.26% | |
| Standard BioTools Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +2.42% | +4.26% | |
| Form 8-K/A STANDARD BIOTOOLS INC. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +1.80% | +11.89% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | -0.93% | -0.66% | |
| Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences | Press release | GlobeNewswire | -0.93% | -0.66% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | +0.53% | -6.73% | |
| Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026 | Press release | GlobeNewswire | -0.26% | -7.00% | |
| Form S-4 STANDARD BIOTOOLS INC. | SEC filing · Form S-4 | SEC EDGAR | +0.02% | -6.20% | |
| Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction | Press release | GlobeNewswire | +0.02% | -6.20% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +0.34% | -6.75% | |
| LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | -0.54% | -3.31% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jun 06 | SEC filing · Form 8-K | SEC EDGAR | -14.45% | -29.54% | |
| Standard BioTools and Treeline Biosciences Announce Merger Agreement | Press release | GlobeNewswire | -14.45% | -29.54% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | -14.45% | -29.54% | |
| Form 8-K STANDARD BIOTOOLS INC. For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +10.44% | |
| Form SD STANDARD BIOTOOLS INC. | SEC filing · Form SD | SEC EDGAR | +0.53% | +1.77% | |
| Form 8-K STANDARD BIOTOOLS INC. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -1.79% | +2.68% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.02% | +4.72% | |
| Form 8-K STANDARD BIOTOOLS INC. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -4.98% | -3.15% | |
| Standard BioTools Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | -4.98% | -3.15% | |
| Form ARS STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.40% | +3.18% | |
| Form DEF 14A STANDARD BIOTOOLS INC. For: Jun 17 | SEC filing · Form DEF | SEC EDGAR | -0.40% | +3.18% | |
| Form DEFA14A STANDARD BIOTOOLS INC. | SEC filing · Form DEFA14A | SEC EDGAR | -0.40% | +3.18% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Sep 13 | SEC filing · Form 8-K | SEC EDGAR | +0.60% | +0.42% | |
| Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 | Press release | GlobeNewswire | -0.32% | -1.66% | |
| Form 10-K STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.56% | +3.34% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +0.00% | |
| Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.43% | +0.00% | |
| Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 | Press release | GlobeNewswire | +0.39% | -2.36% | |
| Form 8-K/A STANDARD BIOTOOLS INC. For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | +0.39% | -1.56% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | +3.57% | +0.00% | |
| Standard BioTools Completes Sale of SomaLogic to Illumina | Press release | GlobeNewswire | +3.57% | +0.00% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | +5.47% | +10.79% | |
| Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue | Press release | GlobeNewswire | +5.47% | +10.79% | |
| Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry | Press release | Business Wire | -0.55% | +1.19% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.68% | -4.20% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | -1.68% | -4.20% | |
| Standard BioTools Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | -1.68% | -4.20% | |
| Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 | Press release | GlobeNewswire | +1.95% | +3.13% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Sep 13 | SEC filing · Form 8-K | SEC EDGAR | -1.46% | +2.92% | |
| Form 8-K STANDARD BIOTOOLS INC. For: Aug 28 | SEC filing · Form 8-K | SEC EDGAR | +2.50% | +7.50% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LAB section they belong to.
Where else LAB is measured.
LAB earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Standard BioTools Inc.'s median reaction calculated?
Every labeled LAB news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 350 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of LAB's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LAB's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.